Related Experiment Videos

FHIT alterations in breast cancer

S Ingvarsson1

  • 1Institute for Experimental Pathology, University of Iceland, Reykjavik, Iceland.

Seminars in Cancer Biology
|September 20, 2001
PubMed

Insights

The FHIT gene, a potential tumor suppressor, shows frequent alterations in breast cancer, including deletions and reduced expression. These changes may contribute to tumor development and genome instability.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • The FHIT gene encodes a diadenosine hydrolase implicated in cellular growth control.
  • The Fhit protein is suggested to function as a tumor suppressor, influencing cell proliferation and apoptosis.
  • Alterations in the FHIT gene are frequently observed in various cancers, notably breast cancer.

Purpose of the Study:

  • To investigate the functional roles of the Fhit protein in tumor pathogenesis.
  • To detail the specific aberrations of the FHIT gene and Fhit protein in breast cancer.

Main Methods:

  • Analysis of protein-protein interactions.
  • Studies on cell lines, including tumorogenicity tests.
  • Examination of knockout mouse models.
  • Detection of gene alterations such as deletions, hypermethylation, and changes in RNA/protein expression.

Main Results:

  • Evidence suggests Fhit protein's involvement in cell proliferation and apoptosis, supporting its tumor suppressor role.
  • Common FHIT gene alterations in breast cancer include deletions, DNA hypermethylation, abnormal transcripts, and reduced expression.
  • FHIT gene alterations are linked to genome instability, particularly in BRCA2-mutated breast tumors.

Conclusions:

  • The FHIT gene and Fhit protein play a significant role in tumor suppression.
  • Aberrations in FHIT are prevalent in breast cancer and associated with genomic instability.
  • Understanding FHIT's function is crucial for comprehending breast cancer pathogenesis.

Related Concept Videos